急性轻型卒中合并大血管闭塞的灌注成像与临床结局
这项国际多中心观察性研究纳入569例接受静脉溶栓的轻型卒中(NIHSS≤5)合并前循环大血管闭塞且有灌注成像的患者,比较桥接治疗与单纯静脉溶栓的3个月改良Rankin量表0-1分结局。桥接治疗与较低的良好结局几率相关(OR 0.73,95%CI 0.55-0.96;P=0.03),且不匹配体积修饰该效应(交互P=0.04);不匹配体积<40 mL者桥接治疗结局更差(OR 0.48,95%CI 0.33-0.71)。
要点
- 桥接治疗与较低良好结局几率相关(OR 0.73,95%CI 0.55-0.96;P=0.03)。
- 不匹配体积修饰桥接治疗效应(交互P=0.04)。
- 不匹配体积<40 mL者桥接治疗结局更差(OR 0.48,95%CI 0.33-0.71)。
核心结论
- 在大血管闭塞相关轻型卒中患者中,桥接治疗与单纯静脉溶栓相比与较低的良好结局率相关。
- 不匹配体积是桥接治疗相对于单纯静脉溶栓效应的强修饰因素,尤其在不匹配体积≤40 mL的患者中桥接治疗结局更差。
- 随机试验应考虑加入灌注成像进行患者选择。
研究设计与样本
- 国际多中心观察性研究,连续纳入接受静脉溶栓的轻型卒中(NIHSS≤5)合并前循环大血管闭塞且溶栓前完成灌注成像的患者,其中部分患者接受立即血栓切除术。
- 共纳入569例患者,桥接治疗组172例,单纯静脉溶栓组397例。
- 采用倾向评分逆概率治疗加权处理组间基线差异。
主要发现
- 在全部人群中,桥接治疗与达到改良Rankin量表0-1分的较低几率相关:OR 0.73(95%CI 0.55-0.96);P=0.03。
- 不匹配体积修饰桥接治疗对临床结局的效应(连续不匹配体积的交互P=0.04)。
- 在不匹配体积<40 mL的患者中,桥接治疗与更差结局相关(OR 0.48,95%CI 0.33-0.71);在不匹配体积≥40 mL的患者中,桥接治疗与结局无显著关联(OR 1.14,95%CI 0.76-1.71)。
- 桥接治疗与全部人群中较高的症状性颅内出血发生率相关,但该效应仅见于不匹配体积小的亚组(交互P=0.002)。
关键数值与推荐
- 主要结局为3个月改良Rankin量表评分0-1分。
- 不匹配体积定义为关键低灌注体积减去核心体积。
- 不匹配体积<40 mL者桥接治疗与更差结局相关(OR 0.48,95%CI 0.33-0.71);不匹配体积≥40 mL者桥接治疗与结局无显著关联(OR 1.14,95%CI 0.76-1.71)。
临床怎么用
- 作者认为随机试验应考虑加入灌注成像进行患者选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether bridging therapy (intravenous thrombolysis [IVT] followed by mechanical thrombectomy) is superior to IVT alone in minor stroke with large vessel occlusion is unknown. Perfusion imaging may identify subsets of large vessel occlusion-related minor stroke patients with distinct response to bridging therapy. METHODS: We conducted a multicenter international observational study of consecutive IVT-treated patients with minor stroke (National Institutes of Health Stroke Scale score ≤5) who had an anterior circulation large vessel occlusion and perfusion imaging performed before IVT, with a subset undergoing immediate thrombectomy. Propensity score with inverse probability of treatment weighting was used to account for baseline between-groups differences. The primary outcome was 3-month modified Rankin Scale score 0 to 1. We searched for an interaction between treatment group and mismatch volume (critical hypoperfusion-core volume). RESULTS: Overall, 569 patients were included (172 and 397 in the bridging therapy and IVT groups, respectively). After propensity-score weighting, the distribution of baseline variables was similar across the 2 groups. In the entire population, bridging was associated with lower odds of achieving modified Rankin Scale score 0 to 1: odds ratio, 0.73 [95% CI, 0.55-0.96]; P=0.03. However, mismatch volume modified the effect of bridging on clinical outcome (Pinteraction=0.04 for continuous mismatch volume); bridging was associated with worse outcome in patients with, but not in those without, mismatch volume <40 mL (odds ratio, [95% CI] for modified Rankin Scale score 0-1: 0.48 [0.33-0.71] versus 1.14 [0.76-1.71], respectively). Bridging was associated with higher incidence of symptomatic intracranial hemorrhage in the entire population, but this effect was present in the small mismatch subset only (Pinteraction=0.002). CONCLUSIONS: In our population of large vessel occlusion-related minor stroke patients, bridging therapy was associated with lower rates of good outcome as compared with IVT alone. However, mismatch volume was a strong modifier of the effect of bridging therapy over IVT alone, notably with worse outcome with bridging therapy in patients with mismatch volume ≤40 mL. Randomized trials should consider adding perfusion imaging for patient selection.
引用
- Seners P, Arquizan C, Fontaine L, et al. Perfusion Imaging and Clinical Outcome in Acute Minor Stroke With Large Vessel Occlusion. Stroke. 2022. PMID: 35862225. doi:10.1161/STROKEAHA.122.039182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。